tiprankstipranks
Trending News
More News >
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
Advertisement

Mirum Pharmaceuticals (MIRM) Stock Statistics & Valuation Metrics

Compare
693 Followers

Total Valuation

Mirum Pharmaceuticals has a market cap or net worth of $3.73B. The enterprise value is $2.54B.
Market Cap$3.73B
Enterprise Value$2.54B

Share Statistics

Mirum Pharmaceuticals has 50,237,648 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,237,648
Owned by Insiders9.02%
Owned by Institutions0.39%

Financial Efficiency

Mirum Pharmaceuticals’s return on equity (ROE) is -0.39 and return on invested capital (ROIC) is -16.29%.
Return on Equity (ROE)-0.39
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-16.29%
Return on Capital Employed (ROCE)-0.16
Revenue Per Employee1.01M
Profits Per Employee-263.30K
Employee Count334
Asset Turnover0.50
Inventory Turnover3.64

Valuation Ratios

The current PE Ratio of Mirum Pharmaceuticals is ―. Mirum Pharmaceuticals’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value8.71
Price to FCF
Price to Operating Cash Flow360.11
PEG Ratio

Income Statement

In the last 12 months, Mirum Pharmaceuticals had revenue of 336.89M and earned -87.94M in profits. Earnings per share was -1.85.
Revenue336.89M
Gross Profit255.25M
Operating Income-87.61M
Pretax Income-86.91M
Net Income-87.94M
EBITDA-48.97M
Earnings Per Share (EPS)-1.85

Cash Flow

In the last 12 months, operating cash flow was 8.99M and capital expenditures -10.37M, giving a free cash flow of -1.37M billion.
Operating Cash Flow8.99M
Free Cash Flow-1.37M
Free Cash Flow per Share-0.03

Dividends & Yields

Mirum Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.75
52-Week Price Change77.82%
50-Day Moving Average56.21
200-Day Moving Average47.71
Relative Strength Index (RSI)82.38
Average Volume (3m)640.74K

Important Dates

Mirum Pharmaceuticals upcoming earnings date is Nov 12, 2025, After Close (Confirmed).
Last Earnings DateAug 6, 2025
Next Earnings DateNov 12, 2025
Ex-Dividend Date

Financial Position

Mirum Pharmaceuticals as a current ratio of 3.10, with Debt / Equity ratio of 124.98%
Current Ratio3.10
Quick Ratio2.93
Debt to Market Cap0.16
Net Debt to EBITDA-1.95
Interest Coverage Ratio-6.12

Taxes

In the past 12 months, Mirum Pharmaceuticals has paid 1.03M in taxes.
Income Tax1.03M
Effective Tax Rate-0.01

Enterprise Valuation

Mirum Pharmaceuticals EV to EBITDA ratio is -42.07, with an EV/FCF ratio of 220.78.
EV to Sales6.12
EV to EBITDA-42.07
EV to Free Cash Flow220.78
EV to Operating Cash Flow199.55

Balance Sheet

Mirum Pharmaceuticals has $304.55M in cash and marketable securities with $318.90M in debt, giving a net cash position of $14.35M billion.
Cash & Marketable Securities$304.55M
Total Debt$318.90M
Net Cash$14.35M
Net Cash Per Share$0.29
Tangible Book Value Per Share-$0.51

Margins

Gross margin is 79.02%, with operating margin of -26.00%, and net profit margin of -26.10%.
Gross Margin79.02%
Operating Margin-26.00%
Pretax Margin-25.80%
Net Profit Margin-26.10%
EBITDA Margin-14.54%
EBIT Margin-21.55%

Analyst Forecast

The average price target for Mirum Pharmaceuticals is $80.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$80.80
Price Target Upside8.89% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast62.33%
EPS Growth Forecast48.34%

Scores

Smart Score8
AI Score58
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis